News

Medpage Today on MSN1mon
Study Questions Need to Hold SGLT2 Inhibitors Before Surgery
Preoperative use of SGLT2 inhibitors among patients with ... (Jardiance), ertugliflozin (Steglatro), and the dual SGLT1/2 ...
Hosted on MSN2mon
SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa ... as it has not been observed in trials of selective SGLT2 inhibitors." "These results demonstrate a new mechanism of action -- combined blockade ...
The American Journal of Managed Care3d
SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps
Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 ...
pharmaphorum6y
FDA advisers divided on Sanofi’s oral type 1 diabetes drug
Zynquista is an investigational oral dual SGLT1 and SGLT2 inhibitor under review as an adjunct to insulin for the treatment of adults with type 1 diabetes (T1D). The drug has the potential to ...
Renal & Urology News1mon
Sotagliflozin May Reduce Myocardial Infarction, Stroke Risks in T2DM, CKD
Sotagliflozin, a dual SGLT1/2 inhibitor ... Sotagliflozin is a dual sodium-glucose co-transporter (SGLT)-1 and SGLT2 inhibitor that acts in the gastrointestinal tract and kidneys, respectively.